Phase 4 Plasmodium Vivax Clinical Trials
4 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–4 of 4 trials
Recruiting
Phase 4
ACT vs CQ With Tafenoquine for P. Vivax Mono-infection
Plasmodium Vivax MalariaMalariaMalaria, Vivax
Shoklo Malaria Research Unit606 enrolled1 locationNCT05788094
Recruiting
Phase 4
Southeast Asia Dose Optimization of Tafenoquine
Plasmodium Vivax Malaria
University of Oxford700 enrolled5 locationsNCT04704999
Completed
Phase 4
Therapeutic Efficacy Study (TES) For First Line of Antimalaria Drug (Dihydroartemisinin Piperaquine/DHP) in Two Sentinel Sites in Indonesia
Plasmodium vivax infectionuncomplicated malariaPlasmodium falciparum infection
World Health Organization, Country Office Indonesia142 enrolled1 locationACTRN12622000248763
Recruiting
Phase 4
Efficacy and safety of pyronaridine-artesunate for the treatment of uncomplicated Plasmodium falciparum malaria and chloroquine for the treatment of uncomplicated Plasmodium vivax malaria in Binh Phuoc, Gia Lai and Phu Yen provinces, Viet Nam in 2021.
Patients infected Plasmodium vivaxPatients infected Plasmodium falciparum
World Health Organization42 enrolled3 locationsACTRN12621001743853